鉴定和描述一种新的ergothioneine联的raloxifene的鉴定和特征
Abhijith Rao1, Sivaprasad Putluru1, Prasanth Eapen1
1Pharmaceutical Candidate Optimization, Biocon Bristol Myers Squibb R&D Center, Syngene International Limited, Bengaluru, Karnataka, India.
Drug metabolism and disposition: the biological fate of chemicals
|February 8, 2025
概括
埃尔戈氨酸 (ET) 结合了拉洛西芬 (RX) 反应性代谢物,类似于谷氨 (GSH). 这项研究确定了ET作为一种新的异生菌解毒途径,可能降低药物毒性.
科学领域:
- 药理学 药理学是指药理学的学科.
- 毒理学 毒理学 毒理学
- 生物化学 生物化学
背景情况:
- 拉洛西芬 (RX) 经历氧化生物激活到反应性中间体,通常与谷氨 (GSH) 结合.
- 饮食中含有抗氧化特性的硫氨基酸L-ergothioneine (ET) 在组织中积累.
- 研究了ET在异生菌排毒中的潜在作用,类似于GSH.
研究的目的:
- 调查L-欧戈氨酸 (ET) 是否可以结合在拉洛西芬 (RX) 生物激活过程中形成的反应性中间体.
- 描述新型的欧戈氨酸-拉洛西芬结合物 (RX-ET),并确定其体内相关性和排泄途径.
主要方法:
- 使用老鼠和人类肝脏显微体和肝细胞的体外研究.
- 使用质谱学和NMR对RX-ET结合物的识别和结构特征.
- 在老鼠体内代谢研究,包括胆道管和ET预处理.
主要成果:
- 确定并从结构上证实了一种新型的拉洛西芬 (RX-ET) ergothioneine结合物,ET结合物位于RX的C-17位置.
- RX-ET主要通过胆道分泌被消除.
- 在老鼠中ET预治疗显著增加了ET和RX-ET合物的体内水平.
结论:
- 埃尔戈氨酸 (ET) 作为一种由拉洛芬 (RX) 生物激活产生的反应性物种的结合剂,在体外和体内都能发挥作用.
- ET结合代表了异生菌的额外解毒途径,可能减轻药物诱导的毒性.
- 这一发现突显了ET在异生菌代谢和安全方面的重要作用.
更多相关视频
08:56Detection of Regulated Ergot Alkaloids in Food Matrices by Liquid Chromatography-Trapped Ion Mobility Spectrometry-Time-of-Flight Mass Spectrometry
Published on: November 22, 2024
545
09:07Detecting the Ligand-binding Domain Dimerization Activity of Estrogen Receptor Alpha Using the Mammalian Two-Hybrid Assay
Published on: December 19, 2018
6.3K
相关概念视频
Internal Receptors
69.3K
Many cellular signals are hydrophilic and therefore cannot pass through the plasma membrane. However, small or hydrophobic signaling molecules can cross the hydrophobic core of the plasma membrane and bind to internal, or intracellular, receptors that reside within the cell. Many mammalian steroid hormones use this mechanism of cell signaling, as does nitric oxide (NO) gas.
69.3K
Transducer Mechanism: Nuclear Receptors
1.3K
Nuclear receptors, or NRs, are unique transcription factors that regulate gene transcription and affect the cellular pathways involved in reproduction, development, or metabolism. Their ability to be stimulated by small lipophilic ligands and control vital cellular processes makes them ideal drug targets. Nearly 10-15% of currently prescribed drugs target these receptors.
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
1.3K
